{"id":598260,"date":"2022-05-02T19:32:02","date_gmt":"2022-05-02T19:32:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=598260"},"modified":"2022-05-02T19:32:02","modified_gmt":"2022-05-02T19:32:02","slug":"follicular-lymphoma-market-delveinsights-analysis-of-epidemiology-pipeline-therapies-and-key-companies-working-in-the-domain","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/follicular-lymphoma-market-delveinsights-analysis-of-epidemiology-pipeline-therapies-and-key-companies-working-in-the-domain_598260.html","title":{"rendered":"Follicular Lymphoma Market: Delveinsight&#8217;s Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the domain"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1651472880.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Follicular Lymphoma Market: Delveinsight&#039;s Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the domain \" src=\"https:\/\/www.abnewswire.com\/uploads\/1651472880.jpeg\" alt=\"Follicular Lymphoma Market: Delveinsight&#039;s Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the domain \" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s \u201cFollicular Lymphoma Market Insights, Epidemiology, and Market Forecast-2032\u2033 report offers an in-depth understanding of the Follicular Lymphoma, historical and forecasted epidemiology as well as the Follicular Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\"><strong>DelveInsight<\/strong> has launched a new report on &#8220;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/follicular-lymphoma-market-insights?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Follicular Lymphoma Market<\/a> Insights, Epidemiology, and Market Forecast-2032&rdquo;.<\/p>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s<strong> &ldquo;Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast-2032&Prime;<\/strong> report offers an in-depth understanding of the Follicular Lymphoma, historical and forecasted epidemiology as well as the Follicular Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><em><strong>Some of the key facts of the Follicular Lymphoma Market Report:<\/strong><\/em><\/p>\n<ul style=\"text-align: justify;\">\n<li><em>As per the study in <\/em><strong><em>2015<\/em><\/strong><em>, in the sub-type analyses, the incidence of Follicular Lymphoma was 3.23 per <\/em><strong><em>100,000<\/em><\/strong><em> people<\/em><\/li>\n<li><em>According to the American Cancer Society, <\/em><strong><em>77,240 cases<\/em><\/strong><em> of non-Hodgkin lymphoma were diagnosed by the year 2020<\/em><\/li>\n<li><em>Of all the cases Follicular Lymphoma constitute approximately 20% of the NHL cases<\/em><\/li>\n<li><em>Each year around <\/em><strong><em>15-20k<\/em><\/strong><em> people in the United States are diagnosed with Follicular Lymphoma<\/em><\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request a sample for the Report: <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/follicular-lymphoma-market-insights?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">https:\/\/www.delveinsight.com\/sample-request\/follicular-lymphoma-market-insights<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">Key benefits of the report:<\/p>\n<ol style=\"text-align: justify;\">\n<li>Follicular Lymphoma market report covers a descriptive overview and comprehensive insight of the Follicular Lymphoma Epidemiology and Follicular Lymphoma&nbsp; market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/li>\n<li>The Follicular Lymphoma market report provides insights on the current and emerging therapies.<\/li>\n<li>Follicular Lymphoma market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n<li>The Follicular Lymphoma market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Follicular Lymphoma market.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">Got queries? Click here to know more about the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/follicular-lymphoma-market-insights?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Follicular Lymphoma Market Landscape<\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Follicular Lymphoma Overview:<\/strong><\/p>\n<p style=\"text-align: justify;\">According to the Lymphoma Research Foundation, Follicular Lymphoma (FL) is a slow-growing or indolent form of non-Hodgkin Lymphoma (NHIL) that arises from B-Lymphocytes. Follicular Lymphoma, a subtype accounts for 20-30% of all NHIL cases. Follicular Lymphoma is a slowly growing lymphoma, but in some cases, it may grow rapidly.<\/p>\n<p style=\"text-align: justify;\">Diagnosis of Follicular Lymphoma (FL) is done by excisional lymph node or tissue therapy. The average age of diagnosis for Follicular Lymphoma is 60-65 years and is rare in young people. The treatment of Follicular Lymphoma is based on the severity of associated symptoms and the rate of cancer growth.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Follicular Lymphoma Symptoms:<\/strong><\/p>\n<p style=\"text-align: justify;\">The symptoms of Follicular Lymphoma include-<\/p>\n<ul style=\"text-align: justify;\">\n<li>Painless swelling in the lymph nodes, around the neck, groin, stomach<\/li>\n<li>Sudden shortness of breathing<\/li>\n<li>Body Fatigue<\/li>\n<li>Night sweats<\/li>\n<li>Sudden Weight Loss<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Follicular Lymphoma Market&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">The dynamics of the Follicular Lymphoma market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Abexinostat, Tisagenlec leucel, Kymriah (tisagenlecleucel), and others during the forecasted period 2019-2032.<\/p>\n<p style=\"text-align: justify;\"><strong>Follicular Lymphoma Pipeline Therapies:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Tazverik(Tazemetostat)<\/li>\n<li>Abexinostat<\/li>\n<li>ME-401<\/li>\n<li>Tisagenlec leucel<\/li>\n<li>Parsaclisib(IBI376)<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Follicular Lymphoma Pipeline Key Companies:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Epizyme<\/li>\n<li>Xynomic Pharmaceuticals<\/li>\n<li>MEI Pharma<\/li>\n<li>Novartis Pharmaceuticals<\/li>\n<li>Innovent Biologic<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;1. Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis<\/p>\n<p style=\"text-align: justify;\">4. Follicular Lymphoma Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Follicular Lymphoma Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Follicular Lymphoma Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Follicular Lymphoma Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Follicular Lymphoma&nbsp;<\/p>\n<p style=\"text-align: justify;\">9. Follicular Lymphoma Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Follicular Lymphoma Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Follicular Lymphoma Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Follicular Lymphoma Market Analysis (2018&ndash;2030)<\/p>\n<p style=\"text-align: justify;\">14. Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Market drivers<\/p>\n<p style=\"text-align: justify;\">16. Market barriers<\/p>\n<p style=\"text-align: justify;\">17. Appendix<\/p>\n<p style=\"text-align: justify;\">18. Follicular Lymphoma Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Click here to read more about <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/follicular-lymphoma-market-insights?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Follicular Lymphoma Market Outlook 2032<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports:<\/strong><\/p>\n<p style=\"text-align: justify;\">Follicular Lymphoma Epidemiology<\/p>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s &#8216;<a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/follicular-lymphoma-market-insights?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Follicular Lymphoma&nbsp; Epidemiology<\/a> Forecast to 2032&#8242; report delivers an in-depth understanding of the disease, historical and forecasted Follicular Lymphoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.<\/p>\n<p style=\"text-align: justify;\">It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_57048.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Gaurav Bora<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=follicular-lymphoma-market-delveinsights-analysis-of-epidemiology-pipeline-therapies-and-key-companies-working-in-the-domain\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +91 9568243403<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=follicular-lymphoma-market-delveinsights-analysis-of-epidemiology-pipeline-therapies-and-key-companies-working-in-the-domain\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight\u2019s \u201cFollicular Lymphoma Market Insights, Epidemiology, and Market Forecast-2032\u2033 report offers an in-depth understanding of the Follicular Lymphoma, historical and forecasted epidemiology as well as the Follicular Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/follicular-lymphoma-market-delveinsights-analysis-of-epidemiology-pipeline-therapies-and-key-companies-working-in-the-domain_598260.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[447,405,417,406,423],"tags":[],"class_list":["post-598260","post","type-post","status-publish","format-standard","hentry","category-Education","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/598260","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=598260"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/598260\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=598260"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=598260"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=598260"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}